ACE2 and viral pneumonia: In the respiratory tract, COVID-19 has an affinity for lung epithelial cells as they have angiotensin-converting enzyme 2 (ACE2) receptors to which the viral spike glycoprotein binds, causing viral pneumonia and acute respiratory distress syndrome.